NICOGEN INC has a total of 22 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and New Zealand. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LABORATORI GUIDOTTI S P A, JANSFAT BIOTECHNOLOGY CO LTD and ONCOETHIX SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 3 | |
#3 | New Zealand | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tyndale Rachel F | 17 |
#2 | Sellers Edward M | 15 |
#3 | Sellers Edward Moncrieff | 2 |
#4 | Tyndale Rachel | 2 |
#5 | Sellers Edward | 2 |
#6 | Glassco William | 1 |
#7 | Damaj M Imad | 1 |
#8 | Mathews James Madison | 1 |
#9 | Etheridge Amy Sue | 1 |
#10 | Martin Billy R | 1 |
Publication | Filing date | Title |
---|---|---|
US2008319025A1 | Therapeutic and Diagnostic Methods Dependent on CYP2A Enzymes | |
WO2007038874A1 | Grape seed extract and its constituents for use as cyp2a6 inhibitors | |
WO2007006117A1 | Novel cyp2a6 inhibitors | |
AU2003268826A1 | CYP2A enzymes and their use in therapeutic and diagnostic methods | |
US2005032844A1 | Methods for regulating nicotine metabolism | |
NZ506409A | Method for regulating nicotine metabolism which involves selectively inhibiting CYP2A6 and CYP2B6 | |
US6908631B1 | Therapeutic and diagnostic methods dependent on CYP2A enzymes | |
CN1299276A | CYP2A enzymes and their use in therapeutic and diagnostic method | |
AU3432097A | Methods for regulating nicotine metabolism |